The impact of novel medications for obesity on weight stigma and societal attitudes: a narrative review
77 YamazakiD.MotohashiK.KasamaT.HaraY.HisaboriT
The condition also has significant implications for reproductive health, contributing to infertility and pregnancy complications
Standard monitoring includes: Thyroid-stimulating hormone (TSH) levels 6-8 weeks after starting or adjusting semaglutide, then every 6-12 months once stable Free T4 levels if TSH results are abnormal or symptoms suggest thyroid dysfunction More frequent monitoring with oral semaglutide due to the known pharmacokinetic interaction Additional testing if you experience symptoms of hypo- or hyperthyroidism Diabetes and Weight Parameters require ongoing assessment: Hemoglobin A1C every 3 months if therapy changes or not at goal
[DOI] [PMC free article] [PubMed] [Google Scholar] Babalghith AO, Al-kuraishy HM, Al-Gareeb AI, De Waard M, Sabatier JM, et al
10.1093/ibd/izaf009 [DOI] [PMC free article] [PubMed] [Google Scholar] 80.Coburn LA, Horst SN, Chaturvedi R, Brown CT, Allaman MM, Scull BP, et al
